Passion for Veterinary Innovations
modern_veterinary_therapeutics_0914025002.jpg
Français 
Home
Research & development
Quality
Products
News
Business development
Contact
Careers
News
 

Miami, FL October 28, 2015 — Modern Veterinary Therapeutics, LLC announces that the Veterinary Drugs Directorate (VDD) has approved Nerfasin 20TM (xylazine injection - 20mg/mL) in Canada. Nerfasin 20TM, presented in a 25mL vial, is indicated for use in dogs, cats, and cattle when it is desirable to produce a state of sedation accompanied by a shorter period of analgesia. "Modern Veterinary Therapeutics, LLC is pleased to announce this new approval in Canada which further expands our veterinary line of sedative and analgesic products," said Dr. Cuong Tu Ba, President of Modern Veterinary Therapeutics, LLC.

 

modern_veterinary_therapeutics_0914025001.jpg